Clinical Trial Update: Numen Stent Assessment Using OCT Technique in a Single Center Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the Numen Stent in a single-center Phase 2/Phase 3 study using OCT imaging to assess restenosis-related hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Restenosis
• Neointimal Hyperplasia

Drugs mentioned

• Numen Stent

Snippet

Sponsor: International Biomedical Systems S.p.A. | Conditions: Hyperplasia, Restenosis | Phase 2, Phase 3 | Status: UNKNOWN